Latest Cancer vaccine Stories
DALLAS, January 22, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance
MediVet Biologic’s collaboration with researchers at the University of Kentucky’s College of Medicine has led to a groundbreaking novel animal biologic, K9-ACV: an Autologous Cancer Vaccine
New cutting-edge report “Dendritic Cell Cancer Vaccine Market & Clinical Insight” worked out by Kuick Research is now available at MarketPublishers.com. London,
TSX Venture: QPT EDMONTON, Jan. 13, 2015 /PRNewswire/ - Quest PharmaTech Inc.
Industry veteran brings nearly 20 years of pharmaceutical development and licensing experience to the company FREDERICK, Md., Jan.
According to the new report from BCC Research, the global market for cancer vaccines is expected to grow to $4.3 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.3%.
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers PLYMOUTH MEETING, Pa., Dec. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PLYMOUTH MEETING, Pa., Dec. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
LOS ANGELES, Dec. 17, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
SAN DIEGO, Dec. 11, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
- A handkerchief.
- Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
- In general, any miraculous portrait of Christ.